Browsing by Author "Crusoe, Edvan"

Now showing items 1-2 of 2

    • Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma ... 
      Pessoa de Magalhães Filho, Roberto José; Crusoe, Edvan; Riva, Eloisa; Bujan, Willen; Conte, Guilhermo; Navarro Cabrera, Juan Ramon; Garcia, Diana Katerine; Vega, Guilhermo Quintero; Macias, Jose; Oliveros Alvear, Jose Willian; Royg, Mercedes; Neves, Lidiane Andino (Elsevier Inc., 2019)
      © 2018 Elsevier Inc. Latin American countries represents a large fraction of patients who are treated for multiple myeloma in the world and difficulties of access to new agents and real-world practice are important issues. ...
    • Monoclonal gammopathy of renal significance (MGRS): real-world data on outcomes and prognostic factors 
      Gozzetti, Alessandro; Guarnieri, Andrea; Zamagni, Elena; Zakharova, Elena; Coriu, Daniel; Bittrich, Max; Pika, Tomás; Tovar, Natalia; Schutz, Natalia; Ciofini, Sara; Peña, Camila; Rocchi, Serena; Rassner, Michael; Avivi, Irit; Waszczuk Gajda, Anna; Chhabra, Saurabh; Usnarska Zubkiewicz, Lidia; González Calle, Verónica; Mateos, María Victoria; Bocchia, Mónica; Bigi, Flavia; Füllgraf, Hannah; Bhasin Chhabra, Bhavna; Gentile, Massimo; Dávila, Julio; Vesole, David H.; Cavo, Michele; Thapa, Bicky; Crusoe, Edvan; Einsele, Hermann; Legiec, Wojciech; Charlinski, Grzegorz; Jurczyszyn, Artur (Wiley, 2022)
      Monoclonal gammopathy of renal significance (MGRS) is a recognized clinical entity. Literature regarding treatment and its outcomes in MGRS is sparse due to the rarity and misdiagnosis of MGRS. We retrospectively analyzed ...